SYBLEU Stock Price, News & Analysis
Company Description
SYBLEU (OTC Link: SYBE) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $583.7K.
SYBE stock has declined 38.9% over the past year.
This page provides a comprehensive overview of SYBE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
SYBLEU (SYBE) stock. Over the past 12 months, the stock has lost 38.9%. At a market capitalization of $583.7K, SYBE is classified as a micro-cap stock with approximately 99.4M shares outstanding.
Latest News
SYBLEU has 5 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. Key topics include AI. View all SYBE news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
SYBE Company Profile & Sector Positioning
SYBLEU (SYBE) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing SYBE often look at related companies in the same sector, including Bio-Path Hldgs Inc (BPTH), LadRx (LADX), AIBotics (AIBT), Regen Biopharma (RGBP), and Theralink Technologies Inc (THER). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SYBE's relative position within its industry.